- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cancer immunotherapies targeting the PD-1 signaling pathway ; volume:24 ; number:1 ; day:4 ; month:4 ; year:2017 ; pages:1-11 ; date:12.2017
Journal of biomedical science ; 24, Heft 1 (4.4.2017), 1-11, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Iwai, Yoshiko
- Beteiligte Personen und Organisationen
-
Hamanishi, Junzo
Chamoto, Kenji
Honjo, Tasuku
SpringerLink (Online service)
- DOI
-
10.1186/s12929-017-0329-9
- URN
-
urn:nbn:de:1111-201704224030
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Iwai, Yoshiko
- Hamanishi, Junzo
- Chamoto, Kenji
- Honjo, Tasuku
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immunotherapies targeting stimulatory pathways and beyond
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Targeting the PDGF signaling pathway in tumor treatment
Buformin suppresses osteosarcoma via targeting AMPK signaling pathway
Targeting the Wnt/β-catenin signaling pathway in cancer
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
γ-tocotrienol regulates gastric cancer by targeting notch signaling pathway
Natural products targeting the MAPK-signaling pathway in cancer: overview
Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Immunotherapies targeting stimulatory pathways and beyond
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Targeting the PDGF signaling pathway in tumor treatment
Buformin suppresses osteosarcoma via targeting AMPK signaling pathway
Targeting the Wnt/β-catenin signaling pathway in cancer
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
γ-tocotrienol regulates gastric cancer by targeting notch signaling pathway
Natural products targeting the MAPK-signaling pathway in cancer: overview
Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Immunotherapies targeting stimulatory pathways and beyond
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Targeting the PDGF signaling pathway in tumor treatment
Buformin suppresses osteosarcoma via targeting AMPK signaling pathway
Targeting the Wnt/β-catenin signaling pathway in cancer
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
γ-tocotrienol regulates gastric cancer by targeting notch signaling pathway
Natural products targeting the MAPK-signaling pathway in cancer: overview
Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway
Immunotherapies in solid tumors